Abstract
Treatment by the pulmonary route can be used for administration of drugs that act locally in the lungs (e.g. treatment of lung cancer, chronic obstructive pulmonary disease, asthma) or non-invasive administration of drugs that act systemically. The potential of drug delivery systems formed from non-ionic surfactants or natural products i.e. proteins and polysaccharides for pulmonary delivery are discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 3324-3331 |
| Number of pages | 8 |
| Journal | Current Pharmaceutical Design |
| Volume | 22 |
| Issue number | 22 |
| Publication status | Published - 2016 |
Keywords
- drug delivery systems
- non-ionic surfactant vesicles
- nanoparticles
- pulmonary
